Previous 10 | Next 10 |
Balchem ( NASDAQ: BCPC ) is scheduled to announce Q2 earnings results on Friday, July 29th, before market open. The consensus EPS Estimate is $1.00 (+7.5% Y/Y) and the consensus Revenue Estimate is $223.53M (+10.5% Y/Y). Over the last 2 years, BCPC has beaten EPS est...
NEW HAMPTON, N.Y., July 15, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 29 th at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, CEO and President, and Mar...
Basic materials sector plunged 16.3% in Q2 and 10% for the past 12 months. The industry is trading at a PE ratio of 24.3x, lower than its 3-year average PE of 27.1x. Top five gainers in the basic materials sector in Q2 (stocks with a market cap of over $2B): Sigma Lithium ...
Basic materials sector plunged 14.1% for the month of June and 19% on YTD basis. The industry is trading at a PE ratio of 24.3x, lower than its 3-year average PE of 27.1x. Analysts are positive on the Construction Materials industry with annual earnings growth expectation of 19% ove...
Balchem is a long-term winner, driven by sound capital allocation and a strong positioning of the business. I like the business a lot, but valuations remain demanding. After a recent pullback, valuations start to slowly cool off a bit, yet I would like to see further pullbacks bef...
NEW HAMPTON, N.Y., June 21, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, today announced that it completed its acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin...
Balchem (NASDAQ:BCPC) signed a definitive agreement to acquire Oslo, Norway-headquartered Kappa Bioscience, science-based manufacturer of specialty vitamin K2 for the human nutrition industry. Vitamin K2 is a fast-growing specialty vitamin that plays a crucial role in the human...
NEW HAMPTON, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, has signed a definitive agreement to acquire Kappa Bioscience AS (“Kappa”), a leading science-based manufacturer of s...
Balchem operates in key industries by providing critical components. Gross profit and EBITDA margins are healthy and stable. The company deleveraged its balance sheet almost completely and a new growth phase is in front of us. The dividend is very safe as the cash payout ratio...
The following slide deck was published by Balchem Corporation in conjunction with their 2022 Q1 earnings call. For further details see: Balchem Corporation 2022 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
MONTVALE, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal second quarter ended June 30, 2024. The Company reported quarterly net sales of $234.1 million, quarterly net earnings of $32.1 million, adjuste...
2024-07-20 01:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...